Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
LAS VEGAS, March 25, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading ...
Ainnova has hired an ophthalmologist, who is assisting in drafting the requirements for the clinical trial protocol that the Company's Contract Research Organization (CRO), Fortrea, has requested.
2d
GlobalData on MSNFDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatmentImunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.
Data in and of itself can be interesting, but the true value of data lies in how you use it and the insights that come from ...
Cancer screening tests can be divided into early detection and preventive tests.1 Early-detection tests (eg, mammography for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results